SCHEMBL8009978

SCHEMBL8009978

CC(C(=O)NC(=O)Cc1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 4/20 0.56
▸ CNR1 P21554 2/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ MAPT P10636 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ HDAC8 Q9BY41 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ ERCC1 P07992 1/20 0.48
▸ ERCC4 Q92889 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ EPHX2 P34913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22808478 0.81 EPHX2 (0.63) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL16431179 0.81 MEN1 (0.52) CNR2CNR1ALDH1A1HPGDMEN1
SCHEMBL22808480 0.80 ERCC1 (0.63) CNR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL22873024 0.79 EPHX2 (0.60) ALDH1A1HPGDMEN1KMT2ACYP3A4
SCHEMBL699925 0.78 MEN1 (0.71) CNR2CNR1ALDH1A1HPGDMEN1
SCHEMBL27906831 0.78 PSMB8 (0.48) CNR2ALDH1A1HPGDMEN1KMT2A
SCHEMBL13074658 0.77 TSHR (0.52) CNR2CNR1ALDH1A1MAPTHPGD
SCHEMBL5431716 0.77 TSHR (0.52) CNR2CNR1ALDH1A1MAPTHPGD
SCHEMBL10826310 0.76 LARS1 (0.54) CNR2ALDH1A1MEN1KMT2AHDAC8
SCHEMBL5272639 0.76 SLC1A2 (0.49) POLBERCC1ERCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 — — US disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 — — US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 — — US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 — — US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 — — US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 — — US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 — — US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 — — EP disclosed
Send feedback